Benaim Ely
Chief Medical Officer at NVCR
- Sold, on record
- $5.7M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Aug 3, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NVCRNovoCure LtdChief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NVCRPlan not statedMay 12, 2021 2021
Sold 1,943 shares at $180.48 ($351k)
Benaim Ely, Chief Medical Officer
Sold 6.3% of holdings ($5.6M position)29,054 shares left0.7x usual sizeFiling
- 2 Form 4 sale NVCRPlan not statedMay 27, 2021 +15 days
Sold 1,833 shares at $200.00 ($367k)
Benaim Ely, Chief Medical Officer
Sold 5.9% of holdings ($6.2M position)29,054 shares left0.7x usual sizeFiling
- 3 Form 4 sale NVCRPlan not statedAug 2, 2021 +67 days
Sold 1,187 shares at $154.63 ($184k)
Benaim Ely, Chief Medical Officer
Sold 4% of holdings ($4.6M position)28,608 shares left0.5x usual sizeFiling
- 4 Form 4 sale NVCRPlan not statedAug 3, 2021 +1 day
Sold 464 shares at $150.11 ($70k)
Benaim Ely, Chief Medical Officer
Sold 1.6% of holdings ($4.3M position)28,144 shares left0.2x usual sizeFiling
- 5 Form 4 sale NVCRPlan not statedMar 4, 2022 +213 days
Sold 2,313 shares at $71.83 ($166k)
Benaim Ely, Chief Medical Officer
Sold 5.1% of holdings ($3.3M position)43,257 shares left1.2x usual sizeFiling
- 6 Form 4 sale NVCRPlan not statedMay 11, 2022 +68 days
Sold 4,205 shares at $63.17 ($266k)
Benaim Ely, Chief Medical Officer
Sold 10.8% of holdings ($2.5M position)34,846 shares left2x usual sizeFiling
- 7 Form 4 sale NVCRPlan not statedAug 2, 2022 +83 days
Sold 437 shares at $69.66 ($30k)
Benaim Ely, Chief Medical Officer
Sold 1.2% of holdings ($2.4M position)34,631 shares left0.2x usual sizeFiling
- 8 Form 4 sale NVCRPlan not statedAug 3, 2022 +1 day
Sold 5,959 shares at $73.73 ($439k)
Benaim Ely, Chief Medical Officer
Sold 17.2% of holdings ($2.6M position)28,672 shares left2.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | Aug 4, 2022 | NVCR | Chief Medical Officer | Form 4 sale | 5,959 | $439k | 17.2% | Plan not stated | SEC |
| Aug 2, 2022 | Aug 3, 2022 | NVCR | Chief Medical Officer | Form 4 sale | 437 | $30k | 1.2% | Plan not stated | SEC |
| May 11, 2022 | May 12, 2022 | NVCR | Chief Medical Officer | Form 4 sale | 4,205 | $266k | 10.8% | Plan not stated | SEC |
| Mar 4, 2022 | Mar 7, 2022 | NVCR | Chief Medical Officer | Form 4 sale | 2,313 | $166k | 5.1% | Plan not stated | SEC |
| Aug 3, 2021 | Aug 4, 2021 | NVCR | Chief Medical Officer | Form 4 sale | 464 | $70k | 1.6% | Plan not stated | SEC |
| Aug 2, 2021 | Aug 3, 2021 | NVCR | Chief Medical Officer | Form 4 sale | 1,187 | $184k | 4.0% | Plan not stated | SEC |
| May 27, 2021 | May 28, 2021 | NVCR | Chief Medical Officer | Form 4 sale | 1,833 | $367k | 5.9% | Plan not stated | SEC |
| May 12, 2021 | May 14, 2021 | NVCR | Chief Medical Officer | Form 4 sale | 1,943 | $351k | 6.3% | Plan not stated | SEC |
| May 11, 2021 | May 12, 2021 | NVCR | Chief Medical Officer | Form 4 sale | 4,095 | $755k | 11.7% | Plan not stated | SEC |
| Apr 13, 2021 | Apr 15, 2021 | NVCR | Chief Medical Officer | Form 4 sale | 5,958 | $1.2M | 15.2% | Plan not stated | SEC |
| Mar 5, 2021 | Mar 9, 2021 | NVCR | Chief Medical Officer | Form 4 sale | 2,918 | $384k | 8.1% | Plan not stated | SEC |
| Mar 4, 2021 | Mar 5, 2021 | NVCR | Chief Medical Officer | Form 4 sale | 5,363 | $784k | 12.9% | Unusual | SEC |
| Dec 21, 2020 | Dec 22, 2020 | NVCR | Chief Medical Officer | Form 4 sale | 2,484 | $389k | 7.8% | Plan not stated | SEC |
| Aug 3, 2020 | Aug 5, 2020 | NVCR | Chief Medical Officer | Form 4 sale | 660 | $50k | 2.2% | Plan not stated | SEC |
| Jul 31, 2020 | Aug 3, 2020 | NVCR | Chief Medical Officer | Form 4 sale | 341 | $26k | 1.1% | Plan not stated | SEC |
| May 12, 2020 | May 14, 2020 | NVCR | Chief Medical Officer | Form 4 sale | 2,595 | $168k | 17.1% | Plan not stated | SEC |
| May 11, 2020 | May 12, 2020 | NVCR | Chief Medical Officer | Form 4 sale | 1,611 | $103k | 9.6% | Plan not stated | SEC |